Deskpro Now Available on the AWS European Sovereign Cloud
18.3.2026 14:00:00 CET | Business Wire | Press release
Deskpro has deployed its help desk platform on the AWS European Sovereign Cloud, extending access to AI-powered support for organizations that need to meet strict EU data residency and sovereignty requirements
Today, Deskpro, provider of the secure AI-powered help desk platform, announced that it is a partner for the AWS European Sovereign Cloud, a new, independent cloud for Europe that is backed by strong technical controls, sovereign assurances, and legal protections designed to meet the needs of European governments and enterprises.
Becoming an AWS European Sovereign Cloud partner strengthens Deskpro’s ability to support customers deploying environments within the AWS European Sovereign Cloud, and reinforces its commitment to supporting organizations for which data residency, governance, and regulatory alignment are non-negotiable.
“European organizations face growing complexity around data sovereignty and regulatory compliance,” said Brad Murdoch, CEO of Deskpro. “By becoming an AWS European Sovereign Cloud partner, we’re ensuring our customers can access the most advanced help desk technology while maintaining full control over their data and meeting the stringent requirements of EU regulations.”
As an AWS European Sovereign Cloud partner, Deskpro now supports organizations deploying its platform within the fully featured, independently operated sovereign cloud launched by AWS. Deploying on the AWS European Sovereign Cloud enables Deskpro to offer its advanced help desk capabilities with additional choice to meet the most stringent sovereignty requirements without compromising on the full power of AWS. Deskpro customers can now benefit from:
- EU Data Residency Assurance: The AWS European Sovereign Cloud infrastructure is entirely located within the EU and operated by EU residents. It is physically and logically separate from other AWS Regions, and has no critical dependencies on non-EU infrastructure.
- Support for Highly Regulated Sectors: Public sector organizations and companies in healthcare, finance, and critical infrastructure that require additional sovereignty controls can now take advantage of AI-powered help desk capabilities.
- Reduced Compliance Complexity: Customers who need to store data in a specific geographic location to meet data residency requirements or run latency-sensitive applications can also choose to run their workloads in AWS Local Zones, which are parented to an AWS Region and help bring AWS infrastructure closer to end-users and business centers.
- Future-Ready Deployment Options: Customers gain flexibility in how they deploy Deskpro with support for maintaining the highest standards of security, compliance, and control over their support infrastructure.
Deskpro’s help desk platform supports customer and employee interactions across every channel, powered by each company’s AI of choice, with comprehensive security, compliance, and data privacy options. Trusted by organizations across private and public sectors, including aerospace and defense, healthcare, financial services, government, high tech and more, Deskpro combines powerful AI capabilities with flexible deployment models to meet the most stringent regulatory and sovereignty requirements.
Deskpro Cloud and Deskpro Private are generally available in AWS Marketplace. Visit Deskpro to start a free trial, explore purchasing options, and see how the platform can improve support operations while maximizing AWS investments.
Resources
- Deskpro website
- Follow Deskpro on LinkedIn
About Deskpro
Deskpro is the developer of AI-driven help desk software that empowers organizations worldwide to deliver exceptional customer and employee experiences that translate directly into tangible ROI, through improved customer and agent retention. Deskpro is the only help desk platform with enterprise-grade security, compliance, and data privacy, enabling all organizations to adopt and deploy AI, even in the most regulated industries and sovereign environments. Deskpro is available as a cloud service, and can also be deployed in VPCs, on-premise, private clouds, and sovereign clouds. Trusted by leading enterprises worldwide in banking, technology, financial services, healthcare systems, aerospace and defense, as well as government agencies, Deskpro is led by experts in enterprise software, customer experience, and customer support. Learn more at deskpro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260318730994/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)4.5.2026 14:00:00 CEST | Press release
Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patients Takeda (TSE:4502/NYSE:TAK) today announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in patients with Primary Immunodeficiency Disease (PID), met its primary endpoint, which demonstrated pharmacokinetic (PK) comparability between the investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) with Recombinant Human Hyaluronidase] and HYQVIA [Immune Globulin Infusion (Human) 10% with Recombinant Human Hyaluronidase]. Additionally, secondary endpoints showed that TAK-881, a SCIG 20% facilitated with hyaluronidase, demonstrated safety, efficacy and tolerability profiles comparable to HYQVIA, an established SCIG 10% facilitated with hyaluronidase. These findings support the potential of TAK-881 to deliver the required immunoglobulin (IG) dose for PID patients in half the volume of HYQVIA, reducing infusion duratio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom